Appili Therapeutics Inc. (APLIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0220
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Appili Therapeutics Employees
As of March 31, 2023, Appili Therapeutics had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees increased by 1 or 12.50% compared to the previous year.
Employees
9
Change (1Y)
1
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
2.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 9 | 1 | 12.50% |
Mar 31, 2022 | 8 | -8 | -50.00% |
Mar 31, 2021 | 16 | 4 | 33.33% |
Mar 31, 2019 | 12 | -3 | -20.00% |
Mar 31, 2018 | 15 | - | - |
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Longduoduo Company | 49 |
Appili Therapeutics News
- 22 days ago - Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025 - GlobeNewsWire
- 5 weeks ago - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update - GlobeNewsWire
- 2 months ago - Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025 - GlobeNewsWire
- 5 months ago - Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. - GlobeNewsWire
- 5 months ago - Appili Therapeutics reports Q2 results - Seeking Alpha
- 5 months ago - Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 - GlobeNewsWire
- 6 months ago - Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders - Business Wire
- 6 months ago - Appili Therapeutics Announces Results of Special Meeting of Shareholders - GlobeNewsWire